NexgenRx (NXG) Stock Chart & Stock Price History C$0.30 +0.02 (+7.14%) As of 06/18/2025 03:58 PM Eastern Add Compare Share Share Chart Stock AnalysisChartBuy This Stock NexgenRx Stock Price Performance The NexgenRx (NXG) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 7.14%, with a year-to-date return of 9.09%. In the past month, the stock has remained steady at 0.00%, reflecting recent market activity. As of the latest close, NexgenRx traded at C$0.30 with a market cap of C$21.28 million and volume of 8,000 shares. Five years ago, the stock traded at C$0.20, representing a 50.00% increase over that period. At the time, it had a market cap of C$11.19 million and a volume of 700 shares. Receive NXG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+7.14%1 Month Performance0.00%3 Month Performance+15.38%Year-To-Date Performance+9.09%1 Year Performance+7.14%5 Year Performance+50.00% NXG Stock Chart for Sunday, June, 22, 2025 NXG Chart by TradingView NexgenRx Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/20/2025C$0.30C$0.30C$0.30C$0.308,000 shsC$21.28 million06/19/2025C$0.30C$0.30C$0.30C$0.308,000 shsC$21.28 million06/18/2025C$0.28C$0.30+7.14%C$0.30C$0.308,000 shsC$21.28 million06/17/2025C$0.28C$0.28C$0.28C$0.282,500 shsC$19.86 million06/16/2025C$0.28C$0.28C$0.28C$0.282,500 shsC$19.86 million06/13/2025C$0.30C$0.28-6.67%C$0.28C$0.282,500 shsC$19.86 million06/12/2025C$0.28C$0.30+7.14%C$0.30C$0.304,278 shsC$21.28 million06/11/2025C$0.28C$0.28C$0.28C$0.282,000 shsC$19.86 million06/10/2025C$0.28C$0.28C$0.28C$0.282,000 shsC$19.86 million06/09/2025C$0.28C$0.28C$0.28C$0.282,000 shsC$19.86 million Get the Latest News and Ratings for NXG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter. 06/06/2025C$0.28C$0.28C$0.28C$0.282,000 shsC$19.86 million06/05/2025C$0.28C$0.28C$0.28C$0.282,000 shsC$19.86 million06/04/2025C$0.28C$0.28C$0.28C$0.282,000 shsC$19.86 million06/03/2025C$0.28C$0.28C$0.28C$0.282,000 shsC$19.86 million06/02/2025C$0.28C$0.28C$0.28C$0.282,000 shsC$19.86 million05/30/2025C$0.28C$0.28C$0.28C$0.282,000 shsC$19.86 million05/29/2025C$0.28C$0.28C$0.28C$0.282,000 shsC$19.86 million05/28/2025C$0.29C$0.28-1.75%C$0.28C$0.282,000 shsC$19.86 million05/27/2025C$0.32C$0.29-10.94%C$0.29C$0.295,000 shsC$20.21 million05/26/2025C$0.30C$0.32+6.67%C$0.32C$0.325,001 shsC$22.69 million05/23/2025C$0.30C$0.30C$0.30C$0.3065,000 shsC$21.28 million05/22/2025C$0.30C$0.30C$0.30C$0.3065,000 shsC$21.28 million05/21/2025C$0.30C$0.30C$0.30C$0.3065,000 shsC$21.28 million Related Companies QIPT Stock Chart ONC Stock Chart MDP Stock Chart COV Stock Chart MDNA Stock Chart APS Stock Chart SVA Stock Chart KDA Stock Chart HBP Stock Chart TLT Stock Chart Receive NXG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:NXG) was last updated on 6/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexgenRx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexgenRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
